Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 12,502 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $36.02, for a total value of $450,322.04. Following the transaction, the vice president directly owned 80,384 shares in the company, valued at approximately $2,895,431.68. This represents a 13.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Arteris Trading Down 0.7%
NASDAQ:AIP opened at $37.19 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. The business’s 50 day moving average is $27.36 and its two-hundred day moving average is $19.79. Arteris, Inc. has a 52 week low of $7.56 and a 52 week high of $38.99. The company has a market cap of $1.72 billion, a PE ratio of -47.08 and a beta of 1.98.
Arteris (NASDAQ:AIP – Get Free Report) last announced its quarterly earnings results on Tuesday, May 12th. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.05. The company had revenue of $22.94 million for the quarter, compared to analyst estimates of $21.03 million. On average, analysts predict that Arteris, Inc. will post -0.54 EPS for the current year.
Wall Street Analyst Weigh In
Check Out Our Latest Report on Arteris
Hedge Funds Weigh In On Arteris
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Westerly Capital Management LLC boosted its stake in shares of Arteris by 109.6% during the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock worth $14,392,000 after acquiring an additional 745,000 shares in the last quarter. Nuveen LLC raised its position in shares of Arteris by 872.3% during the fourth quarter. Nuveen LLC now owns 737,281 shares of the company’s stock worth $11,428,000 after purchasing an additional 661,454 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Arteris by 144.7% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock worth $15,696,000 after purchasing an additional 598,840 shares during the period. Granahan Investment Management LLC raised its position in shares of Arteris by 725.7% during the third quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock worth $6,278,000 after purchasing an additional 546,341 shares during the period. Finally, Informed Momentum Co LLC acquired a new stake in shares of Arteris during the fourth quarter worth $5,755,000. 64.36% of the stock is owned by institutional investors.
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Articles
- Five stocks we like better than Arteris
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
